Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2012-04-16Clinical Trial Update: Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite [Phase 2, Phase 3]
This Phase 2/3 trial evaluating ramatroban/montelukast versus montelukast/placebo for early allergic reactions in house-dust mite–sensitive …
-
CLINICAL_TRIALS withdrawal · 2012-04-12Clinical Trial Update: Inhaled Fluticasone Propionate: Effect on Parameters of Bone Metabolism in Patients With Mild to Moderate Asthma [NA]
The clinical trial assessing the effect of inhaled fluticasone propionate on bone metabolism in patients with mild to moderate asthma was wi…
-
CLINICAL_TRIALS withdrawal · 2012-01-24Clinical Trial Update: Correlation Between IgE Parameters and the Response to Omalizumab in Subjects With Severe Asthma
An investigation evaluating the correlation between IgE parameters and response to omalizumab in subjects with severe asthma has been withdr…
-
CLINICAL_TRIALS withdrawal · 2011-12-02Clinical Trial Update: A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge [Phase 1]
A Phase 1 clinical trial evaluating the duration of action of PF-03526299 in asthmatic subjects following an allergen challenge has been wit…
-
CLINICAL_TRIALS withdrawal · 2011-11-23Clinical Trial Update: Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids [Phase 2]
A Phase 2 study of BI 54903, an inhaled corticosteroid, for asthma that was inadequately controlled on low-dose inhaled corticosteroids has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2011-11-22Clinical Trial Update: Olodaterol Bridging Study in Asthma [Phase 2]
The Phase 2 olodaterol bridging study in asthma sponsored by Boehringer Ingelheim has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-07-26Clinical Trial Update: How Airway Remodeling and Hyperresponsiveness Contribute to Airflow Obstruction in Asthma
A clinical trial exploring how airway remodeling and hyperresponsiveness contribute to airflow obstruction in asthma has been withdrawn from…
-
CLINICAL_TRIALS withdrawal · 2011-02-14Clinical Trial Update: Bronchoscopy With Bronchial Biopsies Sub-study of: Persistence of Airway Inflammation and Remodeling in Asthma Remission
A Laval University-sponsored bronchoscopy sub-study on persistence of airway inflammation and remodeling in asthma remission has been withdr…
-
CLINICAL_TRIALS withdrawal · 2007-11-06Clinical Trial Update: A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma [Phase 2]
A Phase 2 dose-finding trial of adalimumab in subjects with refractory asthma was withdrawn.